Skip to content
4D Molecular Therapeutics Inc icon

4D Molecular Therapeutics Inc

FDMTStocksBiotechnologyUnited StatesNasdaqUSD

Price

$12.54

Today

-5.5%

YTD

+72.7%

About

4D Molecular Therapeutics Inc. is a clinical stage biopharmaceutical company focusing on advancements in medical technology. The company operates globally, working towards the delivery of transformative gene therapeutic products to treat severe genetic diseases and cancer. Operating in the biotechnology sector, 4D Molecular Therapeutics Inc. uses its proprietary Therapeutic Vector Evolution platform to create customised gene delivery vehicles that target specific tissue types associated with underlying diseases. The company’s product pipeline targets three therapeutic areas: Ophthalmology, Pulmonology, and Cardiology. Stay up to date on the share price of FDMT by adding it to your eToro watchlist.

Price chart
Closing price history for FDMT (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-4.74
P/S (TTM)9.87
P/B (TTM)1.75
Market cap$713.76M
Cap tierSmall-cap
Industry avg P/E-2.11

Profitability

Gross margin91.17%
EBIT margin-214.24%
Net margin-1929.01%
ROE-43.25%
ROA-37.09%

Earnings & Revenue

Revenue (TTM)$92.01M
Revenue growth (1Y)+278712.1%
EPS (TTM)-$2.72
Free cash flow$-155.97M
Total debt$39.22M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.45
Employees196
Next earnings10 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.